New Delhi: DUSQ, a sleep science and recovery company, has raised ₹24 crore in seed funding led by Fireside Ventures, with participation from Antler India, Climber Capital, Startup Sherpas, Vaishav Investments, Avnish Anand (Founder, CaratLane) and Shivam Puri (CEO, Cipla Health).
The funding marks a significant milestone for DUSQ as it accelerates the development and global expansion of what it describes as the world’s first sleep regulation platform.
The capital raised by DUSQ will be deployed to scale its neuroscience and hardware teams, deepen intellectual property development, strengthen its fully equipped in-house sleep laboratory, and prepare for a U.S. launch into the rapidly expanding global sleep economy.
The investment underscores growing institutional confidence in DUSQ’s deep-science approach to sleep restoration.
Also Read Prantae Solutions Receives TDB Support for Point-of-Care Kidney Diagnostic Technology Proflo-U
Regulation-First Sleep Technology Company
Founded in 2023 by Dr Siddhant Bhargava, Shalmali Kadu, and Mitansh Khurana, DUSQ is a sleep science and recovery company grounded in a regulation-first hypothesis.
In a market largely dominated by wearables that generate sleep scores and dashboards, DUSQ is positioning itself as a regulation-first company.
The core hypothesis driving DUSQ is that modern sleep failure stems from brain–body desynchrony, and that genuine recovery requires biological regulation rather than passive tracking.
The journey of DUSQ began with InnerGize, a stress-focused wearable that gained national visibility through Shark Tank India.
While early traction validated strong consumer demand, the experience revealed a deeper insight: stress was often a symptom, while sleep was the root cause.
Over two years, the team analyzed more than 50 million physiological data points to build a regulation model that connects autonomic signaling and neural downshifting to fragmented recovery. This research-driven approach laid the scientific foundation for what would later become DUSQ.
From InnerGize to DUSQ: A Strategic Rebrand Rooted in Research
Instead of scaling prematurely, DUSQ made the strategic decision to step back and invest in long-horizon research.
This deliberate phase of scientific exploration led to a fundamental rebrand—from InnerGize to DUSQ—anchored in the principle that sleep is a biological process that requires regulation, not just measurement.
Over the past year, the company has conducted structured trials inside its proprietary sleep laboratory, testing autonomic recovery pathways under controlled conditions.
According to the company, early results demonstrate the system’s ability to support sustained recovery cycles and stabilize uninterrupted sleep patterns—marking a shift from merely observing rest to actively facilitating it.
“InnerGize gave us proof of consumer trust, but DUSQ is what happens when you build for the long term,” said Dr Siddhant Bhargava, co-founder of DUSQ.
“We believe the next frontier of health-tech is not more data—it’s restored biological function. We’re not building another tracker; we’re building infrastructure for human recovery. This funding allows us to take an India-built deep-science product into global markets with confidence.”
Also Read: Building for Bharat’s Stores: How Zithara AI Is Rewriting the Offline Retail Playbook
Investor Confidence in Scientific Depth and IP Foundation
Ankur Khaitan, Principal at Fireside Ventures, commented on the investment in DUSQ: “Sleep is emerging as one of the most important health frontiers globally. What stood out for us was the team’s willingness to rethink the problem and build with genuine scientific depth and clear differentiation from day one. With a launch-ready product and strong IP foundation, we believe it can define the global sleep solutions category.”
The ₹24 crore seed round for the company also represents a significant moment for Indian med-tech. Historically, the global sleep technology market has been dominated by U.S. and European players.
Institutional backing for a deep-science platform like DUSQ at this stage signals increasing conviction that globally competitive health technology can be built from India.
As the company prepares for its U.S. launch, the company aims to shift the global conversation from sleep optimization to sleep restoration, reinforcing its regulation-first positioning in the broader health-tech ecosystem.
